Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 44 (1) , 158-166
- https://doi.org/10.1016/j.jhep.2005.10.002
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Initial Response To Percutaneous Ablation Predicts Survival in Patients With Hepatocellular CarcinomaHepatology, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Overview of the SEER-Medicare DataMedical Care, 2002
- Assessing Comorbidity Using Claims DataMedical Care, 2002
- Prognostic prediction and treatment strategy in hepatocellular carcinomaHepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Trends in Survival of Patients With Hepatocellular Carcinoma Between 1977 and 1996 in the United StatesHepatology, 2001
- Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolizationTransplant International, 1998
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983